NEW YORK, Oct. 16 – Hybrigenics of Paris and the Institut Pasteur have expanded their collaborative efforts with an agreement to work together exclusively on a project designed to link functional proteomics and infectious diseases.

Under the terms of the deal, Hybrigenics and the Institut Pasteur, which have been working together since 1998, will validate therapeutic targets that can be used in the treatment of infectious diseases. Hybrigenics will have the exclusive right to any results generated by the collaboration.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.